<DOC>
	<DOCNO>NCT00213876</DOCNO>
	<brief_summary>At present , diagnosis oligodendroglioma make histological radiographic criterion French Mayo-Ste Anne classification . The less frequent grade A oligodendrogliomas characterize vascular contrast RMN evaluation comparatively grade B form . This benign histological subtype relapse case aggressive histology . To determine relapsed case diagnosis , collection tumour begin February 2004 . Then , study design identify diagnostic molecular metabolic marker could eventually use signature characterise grade A versus grade B oligodendrogliomas . The molecular analysis use genomic technique like allelotyping study , quantitative real-time PCR , gene sequencing , serial analysis genomic expression immunohistochemistry , since metabolic study spectroscopic examination vivo tumour . This study include paediatric adult patient follow oligodendrogliomas , medulloblastomas glioma compare different tumour signature . All result correlate survival clinical feature .</brief_summary>
	<brief_title>Research Molecular Metabolic Markers Oligodendrogliomas Comparatively Other Brain Tumours</brief_title>
	<detailed_description />
	<mesh_term>Oligodendroglioma</mesh_term>
	<criteria>Paediatric adult patient ( &gt; 1 year age ) Patient oligodendroglioma medulloblastoma glioma Possibility 3 year followup Patient consent obtain</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Brain tumour</keyword>
	<keyword>oligodendrogliomas</keyword>
	<keyword>allelotyping</keyword>
	<keyword>SAGE</keyword>
	<keyword>Presence molecular abnormality statistically link survival response chemotherapy</keyword>
</DOC>